Doç.Dr. Fatih Türker

Hakkında

Fatih Türker, İç Hastalıkları alanında Medipol Esenler Üniversite Hastanesi doktor kadrosunda yer almaktadır.

Deneyim

• 2023
• Haseki Eğitim ve Araştırma Hastanesi
• Doçent Doktor, Eğitim Görevlisi, Poliklinik Sorumlusu
• 2020 - 2023
• Dahiliye Uzmanı
• 2018 - 2020
• T.C. Demiroğlu Bilim Üniversitesi/Şişli Florence Nightingale Hastanesi
• Dahiliye Uzmanı, Doktor Öğretim Üyesi
• 2015 - 2018
• T.C. Arnavutköy Devlet Hastanesi
• İç Hastalıkları Uzmanı/Klinik İdari Sorumlusu
• 2011 - 2015
• Asistan Doktor / İç Hastalıkları
• 2010 - 2011
• T.C. Boyabat Devlet Hastanesi
• Pratisyen Doktor

Bilimsel yayınlar

• ULUSLARARASI YAYINLAR
• SCİE YAYINLAR
• 1.Oral A, Çavuşoğlu Türker B, Anılır E, Şahin T, Koçak E, Türker F. Association of Euthyroid Thyroid Hormone Levels with Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease. Diabetes Metab Syndr Obes. 2026;19:555563. Published 2026 May 23. doi:10.2147/DMSO.S555563
• 2. Türker F, Kula AC, Yamak M, et al. Prognostic Nutritional Index as a Predictor of Mortality in Hospitalized Geriatric Patients with Chronic Atrial Fibrillation. Int J Gen Med. 2026;19:590453. Published 2026 Mar 31. doi:10.2147/IJGM.S590453
• 3. Çavuşoğlu Türker B, Yamak M, Çetin M, et al. Prognostic Value of the CONUT Score in Predicting All-Cause Mortality in Hospitalized Internal Medicine Patients: A Retrospective Cohort Study. J Clin Med. 2026;15(5):1904. Published 2026 Mar 2. doi:10.3390/jcm15051904
• 4. Yamak M, Çavuşoğlu Türker B, Oral A, Çakır S, Menken Ö, Türker F. The Predictive Utility of Arterial Blood Gas Analysis for ICU Transfer and In-Hospital Mortality Among General Internal Medicine Inpatients. Int J Gen Med. 2026;19:571477. Published 2026 Jan 22. doi:10.2147/IJGM.S571477
• 5: Çavuşoğlu Türker B, Ahbab S, Türker F, Hoca E, Çiftçi Öztürk E, Kula AC,Öztürk H, Urvasızoğlu AÖ, Kalaycı N, Koçak E, Bulut M, Yasun Ö, Ataoğlu HE.
• 6.Comparison of Controlling Nutritional Status Score with Bedside Index forSeverity in Acute Pancreatitis Score and Atlanta Classification for Mortality in Patients with Acute Pancreatitis. J Clin Med. 2024 Jun 11;13(12):3416. doi:10.3390/jcm13123416. PMID: 38929944; PMCID: PMC11205006.
• 7: Hoca E, Arat EK, Arat O, Ahbab S, Kula AC, Öztürk H, Öztürk EÇ, Türker BÇ,Türker F, Ataoğlu HE. Hypermagnesemia is associated with poor outcomes duringhospitalization. Ir J Med Sci. 2024 Apr;193(2):733-739. doi:10.1007/s11845-023-03518-z. Epub 2023 Sep 9. PMID: 37684491.
• 8: Anılır E, Oral A, Turker F, Şahin T, Topçu FS, Yuzer Y, Tokat Y. PredictiveValue of Preoperative 18 Fludeoxyglucose Positron Emission Tomography-ComputedTomography for Survival in Liver Transplantation Due to Hepatocellular Cancer.Transplant Proc. 2024 Jan-Feb;56(1):111-115. doi:10.1016/j.transproceed.2023.12.007. Epub 2024 Jan 11. PMID: 38212168.
• 9: Anilir E, Oral A, Sahin T, Turker F, Yuzer Y, Tokat Y. Factor 5 and Factor 2heterozygous positivity and complications in living donor liver transplantdonors. North Clin Istanb. 2023 Sep 26;10(5):550-555. doi:10.14744/nci.2023.49354. PMID: 37829741; PMCID: PMC10565751.
• 10: Anilir E, Oral A, Sahin T, Turker F, Yuzer Y, Tokat Y. Incidental combinedhepatocellular-cholangiocarcinoma in liver transplant patients: Does it have aworse prognosis? Hepatol Forum. 2023 Sep 20;4(3):97-102. doi:10.14744/hf.2022.2022.0037. PMID: 37822306; PMCID: PMC10564256.
• 11: Çavuşoğlu Türker B, Ahbab S, Türker F, Hoca E, Çiftçi Öztürk E, Kula AC,Öztürk H, Urvasızoğlu AÖ, Bulut M, Yasun Ö, Ataoğlu HE. Systemic Immune-Inflammation and Systemic Inflammation Response Indices are Predictive Markersof Mortality in Inpatients Internal Medicine Services. Int J Gen Med. 2023 Jul 26;16:3163-3170. doi: 10.2147/IJGM.S420332. PMID: 37525647; PMCID: PMC10387250.
• 12: Cavuşoğlu Türker B, Türker F, Ahbab S, Hoca E, Urvasızoğlu AO, Cetin SI,Ataoğlu HE. Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients. Int JGen Med. 2022 Jul 27;15:6301-6307. doi: 10.2147/IJGM.S374246. PMID: 35924178;PMCID: PMC9343174.
• 12: Cavusoglu Turker B, Turker F, Ahbab S, Hoca E, Tahmaz M, Ataoğlu HE. Serumalbumin and FT3/FT4 ratio as additional co-morbidity parameters to predict mortality as a new approach: The Haseki Scoring Index (updated CharlsonComorbidity Index). PLoS One. 2022 Mar 14;17(3):e0264724. doi:10.1371/journal.pone.0264724. PMID: 35286325; PMCID: PMC8920220.
• 13: Türker F, Sahın T, Oral A, Koçak E, Çavuşoğlu Türker B, Niğdelioğlu A, EsraAtaoğlu H. Evaluation of Predisposing Metabolic Risk Factors for PortopulmonaryHypertension in Patients with NASH Cirrhosis. Int J Gen Med. 2022 Jan25;15:859-865. doi: 10.2147/IJGM.S339474. PMID: 35115812; PMCID: PMC8800581.
• 14: Türker F, Oral A, Şahin T, Türker BÇ, Koçak E, Ataoğlu HE, Ahbab S. Does theFT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis? Jnt Med Res. 2021 Nov;49(11):3000605211056841. doi: 10.1177/03000605211056841.PMID: 34763561; PMCID: PMC8593317.
• 15. Sahin T, Oral A, Turker F, Kocak E. Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis? Medicine (Baltimore). 2020 Mar;99(11):e19492. doi: 10.1097/MD.0000000000019492. PMID: 32176089; PMCID:PMC7440066.
• 16: Oral A, Sahin T, Turker F, Kocak E. Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study. Med Sci Monit. 2019 Dec 23;25:9882-9886. doi:10.12659/MSM.920172. PMID: 31868169; PMCID: PMC6939442.
• 17: Oral A, Sahin T, Turker F, Kocak E. Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients. Medicina (Kaunas). 2019 Sep 17;55(9):600. doi: 10.3390/medicina55090600. PMID: 31533345; PMCID: PMC6780528.
• 18: Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. PMID: 27633186.
• 19: Gökmen FY, Ahbab S, Ataoğlu HE, Türker BÇ, Çetin F, Türker F, Mamaç RY, Yenigün M. FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. Clinics (Sao Paulo). 2016 Apr;71(4):221-5. doi: 10.6061/clinics/2016(04)08.PMID: 27166773; PMCID: PMC4825197.
• ULUSAL /TRDİZİN YAYINLAR
• 1. Evaluation of Patients with Hepatic Cirrhosis due to Etiology for the Complication
• Volume: 4Number: 4October 29, 2024 Betül Çavuşoğlu *, Tolga Şahin , Fatih Türker
• 2. An Independent Predictor of Mortality in Hospitalized Patients: Vitamin B12Araştırma Makalesi Betül
• Çavuşoğlu, Kübra Solmaz, Fatih Türker, Esra Ataoğlu (2024), DAHUDER Medical Journal, Volume 4,
• Issue 3, 2024, 64 - 70, 10.56016/dahudermj.1494846
• 3. Evaluation of Metabolic Parameters of Gestational Diabetic Patients in Postpartum PeriodF Türker, BÇ Türker, S Ahbab, E Ataoğlu Haseki Tip Bulteni 56 (2), 136
• 4. Hepatit C’ye bağlı siroz hastalarında hepatosellüler karsinom gelişiminde öngördürücü faktörlerin retrospektif analizi F Türker, B Çavuşoğlu, T Şahin Anatolian Clinic the Journal of Medical Sciences 27 (2), 204-208
• 5. Clinical characteristics and outcomes of hospitalized COVID-19 patients with diabetes: A multi-center, retrospective study in Turkey F Türker, S Ahbab, BÇ Türker, E Ataoğlu, S Öztürk Cumhuriyet Medical Journal 43 (4), 384-395
• 6. Evaluation of dermatology consultations in internal medicine wards: an analysis of 510 cases from a tertiary center TO Akbulut, H Suslu, F Turker, T Atci The Medical Bulletin of Haseki
• 7. Evaluation of the association between gastrointestinal symptoms and laboratory outcomes in hospitalized covid-19 patients S Ahbab, F Turker, BC Turker, AC Kula, FP Ziyadanoglu, P Acar, EC Ak, ..The Medical Bulletin of Haseki
• 8. COVID-19 Hastalarında Nötrofil-Lenfosit Oranının ve Prognostik Nutrisyonel İndeksinin Mortalite Öngördürücülüğü: Retrospektif Bir Çalışma BÇ TÜRKER, H Emre, EÇ ÖZTÜRK, F TÜRKER, HE ATAOĞLU Namık Kemal Medical Journal
• 9. Hepatocellular Cancer and Liver Transplantation; Is There Any Novelty in Prognostic Factors For Survival and Recurrence? E Anılır, A Oral, F Türker, T Şahin, Y Yüzer, Y Tokat Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 15 (1), 24-30
• 10. Non-Alcoholic Fatty Liver and Fatty Pancreas Diseases Associate with Acute PancreatitisS Ahbab, A Keskin, E Hoca, E Ataoğlu, TS Can, F Türker, B Çavuşoğlu Cumhuriyet Medical Journal 44 (4), 436-442
• 11. Serum Cortisol May Serve as a Novel Predictor of Hospital Length of Stay for COVID-19 Patients F Türker, S Ahbab, B Çavuşoğlu, AC Kula, RD Alçelik, HE Ataoglu Southern Clinics of Istanbul Eurasia 33 (3)
• DİĞER/ULUSLARARASI YAYINLAR
• 1. Low serum vitamin D associated with prediabetes R Ayhan, BÇ Türker, S Ahbab, F Türker, HE Ataoğlu Int J Community Med Public Health 5 (9), 3776-81
• 2. Evaluation of Patients with Hepatic Cirrhosis due to Etiology for the Complication B Çavuşoğlu, T Şahin, F Türker DAHUDER Medical Journal 4 (4), 83-88

Çalışma yerleri 1